RT @MakiSugimotoMD: OsiriXの論文引用件数が1,000件をこえました! https://t.co/D83oUJy9N9
OsiriXの論文引用件数が1,000件をこえました!
RT @rossetantoine: What a milestone for #OsiriX ! 1’000 citations for the original article about #OsiriX. https://t.co/C3IRrbJQ8U 🥳 htt…
RT @rossetantoine: What a milestone for #OsiriX ! 1’000 citations for the original article about #OsiriX. https://t.co/C3IRrbJQ8U 🥳 htt…
RT @rossetantoine: What a milestone for #OsiriX ! 1’000 citations for the original article about #OsiriX. https://t.co/C3IRrbJQ8U 🥳 htt…
RT @rossetantoine: What a milestone for #OsiriX ! 1’000 citations for the original article about #OsiriX. https://t.co/C3IRrbJQ8U 🥳 htt…
日本でもプログラム医療機器クラス2に認定された「OsiriX」が文献引用1,000を超えました‼️ Congrats! #OsiriX
RT @rossetantoine: What a milestone for #OsiriX ! 1’000 citations for the original article about #OsiriX. https://t.co/C3IRrbJQ8U 🥳 htt…
RT @rossetantoine: What a milestone for #OsiriX ! 1’000 citations for the original article about #OsiriX. https://t.co/C3IRrbJQ8U 🥳 htt…
What a milestone for #OsiriX ! 1’000 citations for the original article about #OsiriX. https://t.co/C3IRrbJQ8U 🥳 https://t.co/81qsd1Yr7H
OsiriX 2004, the original article, cited by more than 190 citations. http://t.co/bOjhQEkt
OsiriX 2004, the original article, cited by more than 190 citations. http://t.co/bOjhQEkt
RT @rossetantoine: OsiriX 2004, the original article, cited by more than 190 citations. http://t.co/1mYTDUus
Osirixの原著論文は2004年以来、190以上も引用。 RT @rossetantoine OsiriX 2004, the original article, cited by more than 190 citations. http://t.co/M2JVR9w4
OsiriX 2004, the original article, cited by more than 190 citations. http://t.co/bOjhQEkt
RT @pixmeo: OsiriX, the original 2004 article, cited by 168 scientific articles : http://t.co/KBhCLtOA
OsiriXはこれまで原著2004文献、168の科学雑誌に引用 RT@pixmeo OsiriX, the original 2004 article, cited by 168 scientific articles : http://t.co/M2K0oJFe
RT @pixmeo: OsiriX, the original 2004 article, cited by 168 scientific articles : http://t.co/KBhCLtOA
OsiriX, the original 2004 article, cited by 168 scientific articles : http://t.co/KBhCLtOA